Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Belimumab
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Belimumab 120mg powder for solution for infusion vials
1001030Z0AAAAAA
|
Belimumab | Belimumab | Musculoskeletal and Joint Diseases | No data available |
|
Belimumab 400mg powder for solution for infusion vials
1001030Z0AAABAB
|
Belimumab | Belimumab | Musculoskeletal and Joint Diseases | No data available |
|
Benlysta 120mg pdr for concentrate for inf vials
1001030Z0BBAAAA
|
Benlysta | Belimumab | Musculoskeletal and Joint Diseases | No data available |
|
Benlysta 400mg pdr for concentrate for inf vials
1001030Z0BBABAB
|
Benlysta | Belimumab | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.